Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 36 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE CENTRALE DE BRAINE L'ALLEUD from Braine-l'Alleud, company number BE0438709422, closed financial year 2025 with a result of € 22,977 after tax. For that financial year PHARMACIE CENTRALE DE BRAINE L'ALLEUD recorded a gross margin of € 617,583 and equity of € -312,085. Compared with financial year 2024, the result moved from € 28,970 to € 22,977. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ -312,085
▲ € 22,977 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 22,977
▼ 21% vs 2024
Profit after tax over the fiscal year.
€ 86,227
▲ 36% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -373,585.
People and assets in 2025
€ 253,021
▲ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 6,155
Loans from banks and other lenders, long and short.
€ 137,818
▼ 25% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 82,975
▲ 158% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 222,049 | € 232,087 | € 294,557 | € 617,583 | ▲ 110% |
| Profit after taxes | € -3,570 | € -24,660 | € 28,970 | € 22,977 | ▼ 21% |
| Equity | € -339,372 | € -364,032 | € -335,062 | € -312,085 | ▲ € 22,977 |
| Total debts | € 363,561 | € 442,951 | € 439,009 | € 779,697 | ▲ 78% |
| Cash | € 76,073 | € 71,712 | € 63,453 | € 86,227 | ▲ 36% |
| Retained profit | € -400,872 | € -425,532 | € -396,562 | € -373,585 | ▲ € 22,977 |
| Bank debt | € 0 | € 0 | € 0 | € 6,155 | |
| Balance sheet total | € 315,121 | € 369,852 | € 394,880 | € 467,613 | ▲ 18% |
| Employees (FTE) | - | 4.7 | - | - |
Key figures of PHARMACIE CENTRALE DE BRAINE L'ALLEUD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE CENTRALE DE BRAINE L'ALLEUD?
What happened at PHARMACIE CENTRALE DE BRAINE L'ALLEUD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 22,977 (▼ 21% vs 2024). filed late Source: NBB ↗
- Jean-Philippe Leroy stepped down as director. NBB
- ORELYS SRL stepped down as director. NBB
- Jean-Philippe Leroy became a director. NBB
- ORELYS SRL became a director. NBB
- New establishment in Braine-l'Alleud. KBO
- Start of the company according to the CBE. KBO
In short
From € 3,570 loss in 2022 to € 22,977 profit in 2025.
Paid € 171,294 in corporate taxes since 2022.
Best year ever: 2024, with € 28,970 profit.
On average € 49,400 of value added per employee in 2023.
A new publication or filing at PHARMACIE CENTRALE DE BRAINE L'ALLEUD? We notify you, reason included.
Follow PHARMACIE CENTRALE DE BRAINE L'ALLEUDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Jean-Philippe Leroy
Director
Also active at: Les Pharmacies de Gare, FARGAN, LEARGEST, PHARMA 5, ORELYS
since 2020 · until 2026
Managing director · represented by Virginie Delvaulx
Also active at: Les Pharmacies de Gare, PACHECO, FARGAN, LEARGEST
since 2020 · until 2026
Establishments
Establishment units
Physical locations of this company
Avenue Léon Jourez 2
1420 Braine-l'Alleud
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0438.709.422
- VAT number
- BE 0438.709.422
- Registered office
- Avenue Léon Jourez 2, 1420 Braine-l'Alleud
- Names & denominations
- PHARMACIE CENTRALE DE BRAINE L'ALLEUD
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 16 October 1989
- Peppol
- Active · Active since 16 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Detailhandel in cosmetica en toiletartikelen